Literature DB >> 3981226

Neoplastic fever responds to the treatment of an adequate dose of naproxen.

J C Chang, H M Gross.   

Abstract

Twenty-one patients with neoplastic fever due to malignancy were treated with naproxen. A prompt and complete lysis of fever was obtained in 20 patients within 12 hours when an adequate dose of naproxen was given, and a sustained normal temperature was maintained in all responding patients while receiving naproxen except for one in whom a low grade fever recurred. Lysis of fever usually was followed by excessive sweating and subjective symptomatic improvement. However, when naproxen was discontinued in ten patients, febrile state to the pretreatment level recurred in seven patients within three days. This observation suggests naproxen has a definite and effective antipyretic activity against neoplastic fever although it may recur as the drug is discontinued. Naproxen may be a useful adjunctive agent in patients with neoplastic fever for a short-term symptomatic relief.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981226     DOI: 10.1200/JCO.1985.3.4.552

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

1.  Cyclo-oxygenase II inhibitors in the treatment of neoplastic fever.

Authors:  Satheesh K Kathula; Ketan Shah; Hari Polenakovik; Jhansi Koduri
Journal:  Support Care Cancer       Date:  2003-03-01       Impact factor: 3.603

Review 2.  Neoplastic fever: a neglected paraneoplastic syndrome.

Authors:  Jason A Zell; Jae C Chang
Journal:  Support Care Cancer       Date:  2005-04-29       Impact factor: 3.603

Review 3.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

4.  Neoplastic fever in patients with bone and soft tissue sarcoma.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Akihiro Sudo
Journal:  Mol Clin Oncol       Date:  2016-09-21

Review 5.  Febrile neutropenia.

Authors:  J Klastersky
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

6.  Pulmonary Venous Obstruction in Cancer Patients.

Authors:  Chuang-Chi Liaw; Hung Chang; Tsai-Sheng Yang; Ming-Sheng Wen
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

Review 7.  Pancreatic carcinoma masked as fever of unknown origin: A case report and comprehensive review of literature.

Authors:  Ning Shi; Cheng Xing; Xiaoyan Chang; Menghua Dai; Yupei Zhao
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Iliofemoral Venous Thrombosis Mainly Related to Iliofemoral Venous Obstruction by External Tumor Compression in Cancer Patients.

Authors:  Tzu-Yao Liao; Hui-Ching Hsu; Min-Sheng Wen; Yu-Hsiang Juan; Yu-Hsin Hung; Chuang-Chi Liaw
Journal:  Case Rep Oncol       Date:  2016-11-18

9.  The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint.

Authors:  Chuang-Chi Liaw; Hung Chang; Tzu-Yao Liao; Ming-Sheng Wen; Chih-Teng Yu; Yu-Hsiang Juan
Journal:  J Oncol       Date:  2016-09-22       Impact factor: 4.375

10.  Naproxen for the treatment of neoplastic fever: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Hongliang Zhang; Yuyong Wu; Zhongqiu Lin; Xiaobin Zhong; Taotao Liu; Zhenguang Huang; Yufang Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.